VIMTALABSNSEVimta Labs Limited· PharmaceuticalsMediumNeutral
Announced Thu, 15 May · 17:43 IST

Vimta Labs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Vimta Labs has submitted a Regulation 31(4) disclosure to NSE for the financial year ended March 31, 2025. The filing was made by Dr. S P Vasireddi on behalf of the promoters and persons acting in concert. In this disclosure, the promoters have confirmed that they have not created any encumbrance (such as pledge, lien, or charge) on their shares during the year. This is a routine annual compliance requirement under SEBI's takeover regulations.

Likely market impact

This is a neutral to mildly positive signal for shareholders — it confirms that promoters have not pledged or otherwise encumbered their holdings, meaning there is no near-term risk of forced selling or margin calls on promoter-owned shares.